Literature DB >> 22921119

STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.

Arian Laurence1, Shoba Amarnath, Jacopo Mariotti, Yong Chan Kim, Jason Foley, Michael Eckhaus, John J O'Shea, Daniel H Fowler.   

Abstract

Acute graft-versus-host disease (GvHD) is a major cause of mortality in allogeneic bone marrow transplantation (BMT), for which administration of FoxP3(+) regulatory T (Treg) cells has been proposed as a therapy. However, the phenotypic stability of Treg cells is controversial, and STAT3-dependent cytokines can inhibit FoxP3 expression. We assessed whether the elimination of STAT3 in T cells could limit the severity of GvHD. We found STAT3 limited FoxP3(+) Treg cell numbers following allogeneic BMT by two pathways: instability of natural Treg (nTreg) cells and inhibition of induced Treg (iTreg) cell polarization from naive CD4(+) T cells. Deletion of STAT3 within only the nTreg cell population was not sufficient to protect against lethal GvHD. In contrast, transfer of STAT3-deficient naive CD4(+) T cells increased FoxP3(+) Treg cells post-BMT and prevented lethality, suggesting that the consequence of STAT3 signaling may be greater for iTreg rather than nTreg cells during GvHD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921119      PMCID: PMC3441059          DOI: 10.1016/j.immuni.2012.05.027

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  49 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  Foxp3-dependent programme of regulatory T-cell differentiation.

Authors:  Marc A Gavin; Jeffrey P Rasmussen; Jason D Fontenot; Valeria Vasta; Vincent C Manganiello; Joseph A Beavo; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-14       Impact factor: 49.962

3.  IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.

Authors:  Emmanuel Zorn; Erik A Nelson; Mehrdad Mohseni; Fabrice Porcheray; Haesook Kim; Despina Litsa; Roberto Bellucci; Elke Raderschall; Christine Canning; Robert J Soiffer; David A Frank; Jerome Ritz
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

4.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

Review 5.  Clinical application of expanded CD4+25+ cells.

Authors:  Carl H June; Bruce R Blazar
Journal:  Semin Immunol       Date:  2006-02-02       Impact factor: 11.130

6.  Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.

Authors:  Jason S Stumhofer; Arian Laurence; Emma H Wilson; Elaine Huang; Cristina M Tato; Leanne M Johnson; Alejandro V Villarino; Qiulong Huang; Akihiko Yoshimura; David Sehy; Christiaan J M Saris; John J O'Shea; Lothar Hennighausen; Matthias Ernst; Christopher A Hunter
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

Review 7.  Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response.

Authors:  Peter J Murray
Journal:  Curr Opin Pharmacol       Date:  2006-05-18       Impact factor: 5.547

8.  Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.

Authors:  Tuna Mutis; Rozemarijn S van Rijn; Elles R Simonetti; Tineke Aarts-Riemens; Maarten E Emmelot; Louis van Bloois; Anton Martens; Leo F Verdonck; Saskia B Ebeling
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

9.  The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.

Authors:  D A Vallera; P A Taylor; J Sprent; B R Blazar
Journal:  Transplantation       Date:  1994-01       Impact factor: 4.939

10.  Epigenetic control of the foxp3 locus in regulatory T cells.

Authors:  Stefan Floess; Jennifer Freyer; Christiane Siewert; Udo Baron; Sven Olek; Julia Polansky; Kerstin Schlawe; Hyun-Dong Chang; Tobias Bopp; Edgar Schmitt; Stefan Klein-Hessling; Edgar Serfling; Alf Hamann; Jochen Huehn
Journal:  PLoS Biol       Date:  2007-02       Impact factor: 8.029

View more
  100 in total

Review 1.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

2.  STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity.

Authors:  Brian C Betts; Anandharaman Veerapathran; Joseph Pidala; Xue-Zhong Yu; Claudio Anasetti
Journal:  J Leukoc Biol       Date:  2013-09-25       Impact factor: 4.962

3.  Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Kazuyuki Murase; Haesook T Kim; O R Gregory Bascug; Yutaka Kawano; Jeremy Ryan; Ken-ichi Matsuoka; Matthew S Davids; John Koreth; Vincent T Ho; Corey Cutler; Philippe Armand; Edwin P Alyea; Bruce R Blazar; Joseph H Antin; Robert J Soiffer; Anthony Letai; Jerome Ritz
Journal:  Haematologica       Date:  2014-05-23       Impact factor: 9.941

4.  MeCP2 enforces Foxp3 expression to promote regulatory T cells' resilience to inflammation.

Authors:  Chaoran Li; Shan Jiang; Si-Qi Liu; Erik Lykken; Lin-tao Zhao; Jose Sevilla; Bo Zhu; Qi-Jing Li
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

5.  Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10.

Authors:  Kelli P A MacDonald; Laetitia Le Texier; Ping Zhang; Helen Morris; Rachel D Kuns; Katie E Lineburg; Lucie Leveque; Alistair L Don; Kate A Markey; Slavica Vuckovic; Frederik O Bagger; Glen M Boyle; Bruce R Blazar; Geoffrey R Hill
Journal:  J Immunol       Date:  2014-02-28       Impact factor: 5.422

Review 6.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

7.  Leptin receptor signaling in T cells is required for Th17 differentiation.

Authors:  Bernardo S Reis; Kihyun Lee; Melania H Fanok; Cristina Mascaraque; Manal Amoury; Lillian B Cohn; Aneta Rogoz; Olof S Dallner; Pedro M Moraes-Vieira; Ana I Domingos; Daniel Mucida
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

Review 8.  Next generation treatment of acute graft-versus-host disease.

Authors:  J Magenau; P Reddy
Journal:  Leukemia       Date:  2014-06-18       Impact factor: 11.528

9.  Systemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Vaidehi R Chowdhary; Chella S David; Govindarajan Rajagopalan
Journal:  J Immunol       Date:  2014-08-04       Impact factor: 5.422

Review 10.  Signal transducer and activator of transcription 3: a year in review.

Authors:  Lisa R Forbes; Josh Milner; Elie Haddad
Journal:  Curr Opin Hematol       Date:  2016-01       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.